TrialJournal of clinical psychopharmacology2018

Clinical Trial of the Potassium Channel Activator Diazoxide for Major Depressive Disorder Halted Due to Intolerability.

Bashkim Kadriu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.